High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab

PURPOSE: Neutrophils and platelets have been described as tumor-promoting factors, but lymphocytes have been described as tumor-inhibiting factors. The prognostic values of the neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) have been explored in human epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Li, Fang, Jianjiang, Ding, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982528/
https://www.ncbi.nlm.nih.gov/pubmed/32021460
http://dx.doi.org/10.2147/CMAR.S231444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982528/
https://www.ncbi.nlm.nih.gov/pubmed/32021460
http://dx.doi.org/10.2147/CMAR.S231444

Ejemplares similares